Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis ; volume:42 ; number:1 ; day:19 ; month:8 ; year:2023 ; pages:1-3 ; date:12.2023
Journal of experimental & clinical cancer research ; 42, Heft 1 (19.8.2023), 1-3, 12.2023
- Creator
-
Lin, Yifeng
Fan, Lina
Qi, Yadong
Xu, Chaochao
Jia, Dingjiacheng
Jiang, Yao
Chen, Shujie
Wang, Liangjing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-023-02796-w
- URN
-
urn:nbn:de:101:1-2023110414402925815290
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Yifeng
- Fan, Lina
- Qi, Yadong
- Xu, Chaochao
- Jia, Dingjiacheng
- Jiang, Yao
- Chen, Shujie
- Wang, Liangjing
- SpringerLink (Online service)
Other Objects (12)
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines
Untersuchung des Einflusses von Bifidobacterium adolescentis und Dmbt1 auf die Entstehung von NAFLD im Mausmodell
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines
Untersuchung des Einflusses von Bifidobacterium adolescentis und Dmbt1 auf die Entstehung von NAFLD im Mausmodell
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines